The global Minimal Residual Disease Market was valued at USD 2.53 billion in 2024 and is expected to reach USD 9.16 billion by 2034, growing at a CAGR of 13.7%. Increasing prevalence of hematologic cancers, rising demand for precision oncology, and the integration of advanced molecular diagnostic techniques are fueling market growth. Minimal residual...

The Oncology Molecular Diagnostics Market research report highlights market research and industry analysis driven by in-depth business-relevant news. Precision Business Insights has published a report on the global Oncology Molecular Diagnostics Market, estimating its value at USD 4.1 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 12.6% over the forecast...

"Executive Summary Colorectal Cancer Treatment Market Size and Share: Global Industry Snapshot  Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Research and analysis about the key...

Introspective Market Research, a global provider of specialized market intelligence, today released a pivotal study on the global DNA Sequencing Market . The report reveals a genomic revolution underway, driven by a dramatic reduction in sequencing costs and the increasing integration of sophisticated bioinformatics. The market, which stood at USD 11.1 Billion in 2023 , is forecast to reach USD...

"Regional Overview of Executive Summary Medical Cyclotron Market by Size and Share The global medical cyclotron market size was valued at USD 228.20 million in 2025 and is expected to reach USD 466.85 million by 2033, at a CAGR of 9.36% during the forecast period     With the superior Medical Cyclotron Market report, get knowledge...

Introspective Market Research, a key leader in providing analytical market intelligence, today released its in-depth report on the Global Solid Tumor Testing Market . This critical market segment encompasses the entire suite of diagnostic products, technologies, and services used to identify, stage, and manage solid tumors—malignant neoplasms found in organs such as the lung, breast,...